on Bellevue Asset Management AG
Bellevue Medtech & Services Fund Celebrates 15 Years of Growth
Bellevue Asset Management’s Medtech & Services Fund commemorates 15 years of growth, highlighting its consistent outperformance since its 2009 inception. The fund's success reflects the stability and innovation within the healthcare sector, exclusive of drug development. Over 15 years, the fund achieved an impressive cumulative return of 471.2%, with annual growth averaging 12.3%.
The medtech sector has evolved, embracing AI and digital solutions. This transition has enhanced resilience and growth potential, with emerging markets like transcatheter heart valve replacement and glucose monitoring leading expansion. The integration of AI further drives growth, notably in robot-assisted surgery, as seen with Intuitive Surgical's advancements.
Looking forward, ongoing technological innovation and favorable economic conditions, such as anticipated Federal Reserve rate cuts, suggest continued growth opportunities for the sector and the Bellevue Medtech & Services Fund.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Bellevue Asset Management AG news